Metabolic Bone Disease

Metabolic syndrome represents a dangerous combination of metabolic abnormalities that amplify cardiovascular risks. It affects about 1 in 3 U.S. adults, with prevalence rising alongside obesity trends globally. Key diagnostic criteria include waist circumference over 40 inches in men or 35 inches in women, blood pressure ?130/85 mmHg, fasting glucose ?100 mg/dL, triglycerides ?150 mg/dL, and HDL below. Insulin resistance often underlies these issues, promoting fat accumulation around the abdomen (apple-shaped obesity).

Symptoms
Many experience no overt signs until complications arise, as high lipids and pressure are often silent. Noticeable indicators include fatigue, excessive thirst, frequent urination from hyperglycemia, darkened skin patches (acanthosis nigricans), and headaches or dizziness from hypertension. Central obesity remains the most visible marker.

This diagram illustrates metabolic syndrome's complications like heart disease and diabetes branching from core risk factors.

Causes and Risks

Primary drivers include poor diet, sedentary lifestyle, genetics, and aging, with intra-abdominal fat exacerbating inflammation and clotting. It heightens the odds of type 2 diabetes, stroke, fatty liver, and polycystic ovary syndrome. Early detection via blood tests and waist measurement is vital.

Management
Lifestyle shifts—weight loss, exercise, Mediterranean diet, and quitting smoking—can reverse it, supplemented by medications like statins or antihypertensives.